Results
|
2321.
|
|
|
2322.
|
Metabolism, excretion, and mass balance of the HIV-1 integrase inhibitor dolutegravir in humans. [electronic resource] by
- Castellino, Stephen
- Moss, Lee
- Wagner, David
- Borland, Julie
- Song, Ivy
- Chen, Shuguang
- Lou, Yu
- Min, Sherene S
- Goljer, Igor
- Culp, Amanda
- Piscitelli, Stephen C
- Savina, Paul M
Producer: 20140108
In:
Antimicrobial agents and chemotherapy vol. 57
Availability: No items available.
|
|
2323.
|
|
|
2324.
|
|
|
2325.
|
|
|
2326.
|
|
|
2327.
|
|
|
2328.
|
|
|
2329.
|
|
|
2330.
|
|
|
2331.
|
|
|
2332.
|
|
|
2333.
|
|
|
2334.
|
Phase II trial of two different irinotecan schedules with pharmacokinetic analysis in patients with recurrent glioma: North Central Cancer Treatment Group results. [electronic resource] by
- Santisteban, Marta
- Buckner, Jan C
- Reid, Joel M
- Wu, Wenting
- Scheithauer, Bernd W
- Ames, Matthew M
- Felten, Sara J
- Nikcevich, Daniel A
- Wiesenfeld, Martin
- Jaeckle, Kurt A
- Galanis, Evanthia
Producer: 20090715
In:
Journal of neuro-oncology vol. 92
Availability: No items available.
|
|
2335.
|
UGT2B17 genetic polymorphisms dramatically affect the pharmacokinetics of MK-7246 in healthy subjects in a first-in-human study. [electronic resource] by
- Wang, Y-H
- Trucksis, M
- McElwee, J J
- Wong, P H
- Maciolek, C
- Thompson, C D
- Prueksaritanont, T
- Garrett, G C
- Declercq, R
- Vets, E
- Willson, K J
- Smith, R C
- Klappenbach, J A
- Opiteck, G J
- Tsou, J A
- Gibson, C
- Laethem, T
- Panorchan, P
- Iwamoto, M
- Shaw, P M
- Wagner, J A
- Harrelson, J C
Producer: 20120904
In:
Clinical pharmacology and therapeutics vol. 92
Availability: No items available.
|
|
2336.
|
|
|
2337.
|
|
|
2338.
|
|
|
2339.
|
|
|
2340.
|
|